About
Technology
Issues
FAQ
Links
Official Page
Twelve-week Monotherapy with the DPP-4 Inhibitor Vildagliptin Improves Glycemic Control in Subjects with Type 2 Diabetes
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.